ICD10 code of Neurofibromatosis and ICD9 code

The primary ICD-10 code for Neurofibromatosis type 1 is Q85.01, while ICD-9 classified this condition under code 237.71. It is important to note that these diagnostic codes are essential for medical billing, insurance authorization, and clinical documentation for the 725 members of our Neurofibromatosis community and patients worldwide.

What is the clinical classification of Neurofibromatosis?

Neurofibromatosis refers to a group of related genetic disorders that cause tumors to grow on nerve tissue. The most common form, Neurofibromatosis type 1 (NF1), affects approximately 1 in 3,000 individuals globally. Because Neurofibromatosis presents with variable clinical features—ranging from café-au-lait spots to plexiform neurofibromas—precise coding is vital for tracking patient care. While ICD-10 Q85.01 specifically identifies NF1, other variants like Neurofibromatosis type 2 are coded as Q85.02, reflecting the distinct genetic etiology of these conditions.

How are ICD-10 and ICD-9 codes used in Neurofibromatosis management?

Medical coding serves as the universal language between healthcare providers, insurance companies, and researchers. When a patient is diagnosed with Neurofibromatosis, physicians use the ICD-10 system to describe the specific manifestation of the disease. Accurate coding ensures that patients have access to necessary specialist referrals, neuro-imaging (such as MRI scans), and multidisciplinary care. Historically, the ICD-9 code 237.71 was used to document Neurofibromatosis before the transition to the more granular ICD-10 classification system, which allows for better epidemiological tracking of Neurofibromatosis cases.

What are the diagnostic criteria for Neurofibromatosis?

Diagnosis of Neurofibromatosis is primarily clinical, based on the National Institutes of Health (NIH) consensus criteria. A patient typically meets the criteria for a Neurofibromatosis diagnosis if they present with two or more of the following specific clinical features:

• Six or more café-au-lait macules (greater than 5mm in prepubertal children or 15mm in postpubertal individuals).


• Two or more neurofibromas of any type, or one plexiform neurofibroma.


• Freckling in the axillary or inguinal regions.


• Optic pathway glioma.


• Two or more Lisch nodules (iris hamartomas).


• A distinctive osseous lesion, such as sphenoid dysplasia or tibial pseudarthrosis.


• A first-degree relative with a confirmed diagnosis of Neurofibromatosis.


• Identification of a pathogenic NF1 variant through genetic testing.

How does genetic inheritance impact a Neurofibromatosis diagnosis?

Neurofibromatosis type 1 is inherited in an autosomal dominant pattern. This means that an affected individual has a 50% chance of passing the mutation to each offspring. However, approximately 50% of Neurofibromatosis cases occur due to a *de novo* (spontaneous) mutation in the NF1 gene, meaning there is no family history of the disorder. Understanding this genetic foundation is crucial for families navigating the complexities of a Neurofibromatosis diagnosis and seeking genetic counseling.

Next steps

• Consult a geneticist or a neurologist specializing in neurocutaneous disorders to confirm your diagnosis and discuss long-term monitoring.


• Join the DiseaseMaps.org community to connect with 725 other individuals living with Neurofibromatosis for peer support and shared insights.


• Maintain a comprehensive medical file, including your specific ICD-10 diagnosis code, to streamline communication with insurance providers and specialists.


• Review current clinical trials and research opportunities through the NIH or local academic medical centers.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Neurofibromatosis type 1.


• Orphanet: Rare Disease Database (ORPHA:636).


• OMIM (Online Mendelian Inheritance in Man): Neurofibromatosis, type 1 (#162200).


• Children's Tumor Foundation: Clinical guidelines for Neurofibromatosis care.